Skip to content

Link-HF: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation

Link-HF: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03037710
Acronym
LINK-HF
Enrollment
100
Registered
2017-01-31
Start date
2015-06-30
Completion date
2017-01-26
Last updated
2020-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Failure

Brief summary

This is a multi-center, non-randomized, non-interventional study to evaluate the accuracy of a remote monitoring and analytical platform for prediction of heart failure exacerbation. The platform acquires continuous multivariate vital signs from HF patients using a new ambulatory wearable (attached by an adhesive) multi-sensor device and analyzes the data using a novel machine learning algorithm.

Detailed description

The analytics being investigated includes a Similarity-Based Modeling technique, that empirically estimates the expected physiological behavior of a subject based on prior learned dynamic data, for comparison to actual measured behavior from the subject, to reveal discrepancies hidden by normal variation. The measurements are typically an ensemble of vital signs that effectively characterizes the physiological control system of the subject. This technique is multivariate: multiple variables are leveraged, because single variables in isolation have little context - a high heart rate by itself could mean a person is exerting himself, or it could mean his physiology is in distress even though he is not exerting himself. With reference to several other variables, however, such as respiration rate, oximetry and motion/activity, a high heart rate might be recognized as a normal state when accompanied by the corroborating data showing a high respiration rate, a normal oximetry and a high level of motion - the person is exercising. A wearable adhesive multi-sensor device will be used to collect continuous vital sign and other data from study subjects, including heart rate, respiration rate, bodily motion/activity, skin temperature, pulse, electrocardiogram and peripheral capillary oxygen saturation. Subjects are provided with a smartphone or cellular tablet that will be paired with the multi-sensor device to receive data and upload it to the analytics server via cellular network or WiFi internet. Study staff will interact with the subject during visits scheduled for routine heart failure follow-up to capture pre-specified heart failure medical events. All standard of care clinic and hospitalization notes and procedure reports including echocardiograms, right heart catheterizations, pulmonary function tests, six minute walk tests and radiology reports will be collected as they occur.

Interventions

A multi-sensor device to collect continuous vital signs

Sponsors

Josef Stehlik
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Subject must be 18 years old or older 2. NYHA( New York Heart Association Functional Classification) Class II-IV, documented in site's medical record system. 3. Subject able and willing to sign Informed Consent Document. 4. Subject willing and able to perform all study related procedures.

Exclusion criteria

1. Expected LVAD (Left Ventricular Assist Device) implantation or heart transplantation in the next 30 days. 2. Skin damage or significant arthritis, preventing wearing of device. 3. Uncontrolled seizures or other neurological disorders leading to excessive abnormal movements or tremors in the upper body. 4. Pregnant women or those who are currently nursing. 5. Visual/cognitive impairment that as judged by the investigator does not allow the subject to independently follow rules and procedures of the protocol.

Design outcomes

Primary

MeasureTime frameDescription
Detection of Heart Failure Exacerbation Event90 DaysCorrelation of algorithmic alerts generated by a non-invasive telemonitoring system to a verified heart failure exacerbation event, measured in percent accuracy

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026